KIR3DL2 and synovial sarcoma: IPH-4102 is a humanized IgG1 antibody against KIR3DL2 whose potent antitumor properties ex vivo against SS and CTCL primary cells, and in vivo against KIR3DL2-positive tumor cells are achieved mainly through ADCC and ADCP.